
September 9, 2026
New Stroke Rehabilitation Guideline Emphasizes Early, Personalized, and Lifelong Recovery

September 9, 2026
Earth Science Tech Builds Self-Sustaining Healthcare Conglomerate Through Vertical Integration

September 9, 2026
Kairos Pharma CEO to Present at H.C. Wainwright Conference, Highlighting New Approach to Cancer Drug Resistance

September 9, 2026
Expert Warns of Hidden Crisis in UTI Diagnosis, Underscoring Need for Advanced Testing

September 9, 2026
Nutriband CEO to Speak at Nasdaq Biotech Summit, Highlighting Abuse-Deterrent Patch Technology

September 9, 2026
Silo Pharma to Present at IPAC-RS 2026 Nasal Innovation Forum, Highlighting Progress of PTSD Candidate SPC-15

September 9, 2026
Quantum BioPharma’s Lucid-MS Gains FDA Clearance for Phase 2 Trial, Drawing Analyst Buy Rating

September 9, 2026
Helus Pharma CEO to Speak at H.C. Wainwright Conference Amid Promising Clinical Pipeline

September 9, 2026
GeoVax Welcomes Global Mpox Vaccine Stockpile, Highlights GEO-MVA’s Role in Diversifying Supply

September 9, 2026
ORGANA International Brings Nearly Three Decades of Natural Wellness Experience to ECRM

September 9, 2026
Translational Longevity Takes Center Stage: New Report and Boston Summit Aim to Bridge the Gap Between Discovery and Patient Care

September 9, 2026
Wellness Index Report Highlights Translational Longevity as Key to Delivering Longevity Science to Patients

September 9, 2026
Retail Expert Mitch Gould to Share Decades of Experience at ECRM Vitamin, Weight Management & Sports Nutrition Session

September 9, 2026
Tumor Microenvironment Drives Natural Killer Cell Diversity, Reshaping Cancer Immunotherapy Landscape

September 9, 2026
LiverRight and Aegle Medical Solutions Partner to Expand Access to Liver Disease Detection and Care

September 9, 2026
As Phone Bans Spread, Expert Says Real Challenge Is Teaching Kids to Regulate Without Screens

September 9, 2026
Creative Biolabs Expands Single-Cell Multi-Omics and RNA Sequencing Services to Advance Biomedical Research

September 8, 2026
Greenland Mines Advances Rare Earth Strategy with Q4 Biotech Spin-Off and Sarfartoq Acquisition

September 8, 2026
Nano-X Imaging Expands Nanox.ARC Distribution in New England Through New Partnership

September 8, 2026
VERAXA Biotech Appoints Raju Willener as CFO to Drive Capital Strategy and Pipeline Growth

September 8, 2026
Scinai Immunotherapeutics Streamlines Operations to Prioritize NanoAb Platform and CDMO Growth

September 8, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Manufacturing and Capital Milestones

September 8, 2026
Quantum BioPharma Gets FDA Clearance for Phase 2 Trial of First-in-Class MS Drug Candidate

September 8, 2026
Ocumetics Begins Patient Recruitment for Group Two Clinical Surgeries of Its Accommodating Intraocular Lens

September 8, 2026
Quantum BioPharma Gets FDA Green Light for First-in-Class MS Drug Targeting Myelin Repair

September 8, 2026
Quantum BioPharma’s Lucid-MS Gets FDA Clearance for Phase 2 Trial in Multiple Sclerosis

September 8, 2026
Quantum BioPharma Gains FDA Clearance for Lucid-MS Phase 2 Trial in Multiple Sclerosis

September 8, 2026
Quantum BioPharma Cleared to Begin Phase 2 Trial of Lucid-MS for Multiple Sclerosis

September 8, 2026
Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer Amid TONMYA Launch

September 8, 2026
BRYTR DAYS Launches Once-Daily Nutritional Drink Backed by Founder’s Survival Story

September 7, 2026
Youth Tobacco Use Hits Historic Lows, but Adult Smokers Need Better Options, Says PMI U.S. Executive
September 7, 2026
Huawei Mate XT 2 Debuts with LogicFolding Tau Chip, Pushing Boundaries of Foldable Innovation

September 4, 2026
Nanox Imaging Expands U.S. Distribution of Nanox.ARC Through New England Partnership

September 4, 2026
VERAXA Biotech Appoints Veteran Finance Executive Raju Willener as CFO to Drive Capital Strategy and Oncology Pipeline Growth

September 4, 2026
Onco-Innovations Advances ONC010 Toward Clinical Trials with Key Manufacturing Milestones

September 4, 2026
CCHR Urges Full Disclosure of Violent and Suicidal Risks in Psychiatric Drug Labeling























